Immunoassay News and Research

RSS
Researchers explore natural SARS-CoV-2 infection in pet rabbits in France

Researchers explore natural SARS-CoV-2 infection in pet rabbits in France

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Study shows homologous COVID boosters better than heterologous in most kidney transplant recipients

Study shows homologous COVID boosters better than heterologous in most kidney transplant recipients

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company Expands Range of Norovirus-Like Particles

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Booster mRNA vaccination effective in reviving anti-SARS-CoV-2 antibody titers among the elderly

Booster mRNA vaccination effective in reviving anti-SARS-CoV-2 antibody titers among the elderly

Antibody binding response significantly reduced for Omicron compared to other SARS-CoV-2 variants

Antibody binding response significantly reduced for Omicron compared to other SARS-CoV-2 variants

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

Pre-existing immunity against influenza can lower SARS-CoV-2 infection burden and spread

Pre-existing immunity against influenza can lower SARS-CoV-2 infection burden and spread

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

Homologous mRNA and heterologous vaccines elicit high immune responses

Homologous mRNA and heterologous vaccines elicit high immune responses